Lead Analyst – Strategic Analytics at HeartFlow

Santa Rosa, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Medical TechnologyIndustries

Requirements

Expert proficiency in Microsoft Excel, SQL, and Python
Advanced skills in data visualization tools (Tableau) and Microsoft PowerPoint
Proven ability to structure and solve complex, ambiguous business problems using a data-driven approach
Strong understanding of financial modeling and forecasting principles
Exceptional written and verbal communication skills, with the ability to clearly present complex analytical concepts and results to both technical and non-technical audiences, including executive-level management
Bachelor’s degree in a quantitative field such as Statistics, Economics, Finance, Mathematics, Computer Science, or equivalent
3 years relevant experience plus a master’s degree, or 4+ years of progressive experience in strategic analysis, consulting, business intelligence, or corporate strategy, preferably within the medical device, pharmaceutical, or healthcare industries
Preferred: Direct experience with syndicated healthcare data sources (e.g., IQVIA, Definitive Healthcare, claims data)
Preferred: Experience working with publicly traded company data and understanding of investor relations analysis
Preferred: Prior experience leading analytical projects or managing junior staff/contractors

Responsibilities

Design, implement, and maintain key performance indicator (KPI) dashboards and reports used by senior management to monitor business health and strategic progress
Develop and maintain sophisticated analytical models (e.g., forecasting, simulation, optimization) to evaluate potential business strategies
Utilize advanced statistical techniques and data visualization tools (Tableau) to uncover accurate and actionable insights
Partner with cross-functional teams to ensure data integrity, accessibility, and the development of robust data pipelines necessary for strategic analysis
Mentor junior analysts, providing guidance on analytical methodologies, data best practices, and effective communication of insights
Drive continuous improvement in analytical capabilities and processes across the Strategic Analytics function

Skills

Tableau

Forecasting

Simulation

Optimization

Statistical Techniques

Data Visualization

KPI Dashboards

HeartFlow

Non-invasive cardiac testing for heart disease

About HeartFlow

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries, including the United States, the United Kingdom, Japan, and Canada. Unlike many competitors, HeartFlow focuses on providing a comprehensive suite of analyses that enhance treatment planning. The goal of HeartFlow is to improve cardiovascular care by making it safer and more efficient for both patients and healthcare providers.

Redwood City, CaliforniaHeadquarters

2010Year Founded

$858.5MTotal Funding

SERIES_FCompany Stage

HealthcareIndustries

501-1,000Employees

Benefits

Remote Work Options

Stock Options

401(k) Company Match

Risks

Emerging AI-driven competitors could threaten HeartFlow's market share.

Algorithmic bias in AI models could lead to inaccurate diagnoses.

Integration into healthcare systems may face resistance due to complexity and cost.

Differentiation

HeartFlow offers the only combined anatomy, physiology, and plaque analysis for heart disease.

HeartFlow's non-invasive FFRCT Analysis is FDA-cleared and widely available globally.

HeartFlow's AI-driven technology provides personalized 3D heart models for precise diagnostics.

Upsides

HeartFlow closed a $215 million Series F funding round in April 2023.

The global non-invasive cardiac imaging market is projected to grow significantly.

HeartFlow's technology aligns with the trend towards value-based care in healthcare.

Land your dream remote job 3x faster with AI

Try Jobo Free